相关实验视频

Updated: Jul 11, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

在B-ALL中需要类似干细胞的重编程来启动白血病的活性

Vincent Fregona^1,2,3, Manon Bayet^1,2,3, Mathieu Bouttier^1,2,3

¹Université de Toulouse, Inserm, Centre Nationale de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse , Toulouse, France.

The Journal of experimental medicine

|November 6, 2023

概括

该PAX5::ELN瘤基因模型揭示了B细胞急性淋巴细胞白血病 (B-ALL) 如何从前性干细胞发展. 它确定EGR1是白血病细胞抵抗和静止的一个关键因素.

科学领域:

血液学血液学血液学
癌症生物学癌症生物学
分子瘤学分子瘤学

背景情况:

B细胞急性淋巴细胞白血病 (B-ALL) 源于B细胞的遗传改变.
在B细胞中发生的瘤基因对干细胞样性质的重编程尚未完全理解.

研究的目的:

研究PAX5::ELN瘤基因在B-ALL发育中的作用.
阐明瘤基因诱导白血病前干细胞 (LSCs前) 的机制及其特性.

主要方法:

利用PAX5::ELN小鼠模型来研究B-ALL的发病性.
采用H2B-GFP系统来评估白血病发起活性.
综合转录和染色体可访问性数据分析.
构建的转录性监管网络.

主要成果:

在PAX5::ELN模型中证明了差异化阻塞,自我更新和LSC前出现之间的因果关系.
表明PAX5::ELN强制执行IL7r/JAK-STAT通路,破坏分化并诱导静止的前LSCs.
确定这些静止的前-LSCs表现出一种非分化,不成熟的分子程序,类似于人类B-ALL化疗耐药细胞.
揭示了EGR1是前LSC和人类B-ALL爆发中静止和抵抗的潜在调节者.

结论:

该PAX5::ELN瘤基因驱动B-ALL通过创建一个静止的群体,白血病发起前LSCs.
这些前LSCs失去B细胞的身份,并采用一个不成熟的,耐化疗的表型.
EGR1是一种关键的转录因子,参与控制B-ALL中的静止和化疗耐药性.

更多相关视频

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors

Published on: January 1, 2017

相关概念视频

Lineage Commitment

Lineage Commitment

Commitment is the process whereby stem cells:

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Methods of Nuclear Reprogramming

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...